Delivery Order SPE2DB22D9310-SPE2DB25FP0MD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This firm fixed-price delivery order, issued on August 21, 2025, is scheduled for ultimate completion by September 12, 2025, with performance taking place at the vendor's Park Ridge location. The award utilizes no set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a $22,325.76 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on May 30, 2025, for the supply of Xolair 300 mg/2 ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location, with an ultimate completion date of June 23, 2025. This delivery order was issued without a set-aside designation, allowing the company to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 ml syringes. The delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group is executing this order under its larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, is structured as a firm fixed-price delivery order without any set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this order for delivery to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This firm fixed-price delivery order, issued on June 2, 2025, is scheduled for completion by June 24, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,379.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group is registered in the System for Award Management and has maintained...
- The Defense Logistics Agency awarded a $3,424.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector prefilled syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will deliver the product to the same location by the October 17, 2025 completion date. This delivery order was issued without a set-aside designation, allowing the contractor to...
- The Defense Logistics Agency awarded a delivery order valued at $37,137.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on August 26, 2025, carries an ultimate completion date of September 17, 2025, with performance occurring at the vendor's Park Ridge facility. The award was made without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement under DLA's existing...
- The Defense Logistics Agency has awarded a delivery order valued at $3,868.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Xolair 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- SPE2DB22D9310Indefinite Delivery Contract
- SPE2DB22D9310-SPE2DB25FP0MDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml syringes on September 25, 2025. This firm fixed-price delivery order is scheduled for completion by October 17, 2025, with fulfillment from the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its woman-owned small business status. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a single-award vehicle valued at $499,999,999 and valid through November 2026. As a woman-owned small business pharmaceutical wholesaler, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company has maintained a robust portfolio of pharmaceutical product deliveries to the Defense Logistics Agency since its registration in the System for Award Management in 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/25/25 |